Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)

NIMH requires an experimental therapeutics approach for the development and testing of therapeutic interventions, in which studies both evaluate the clinical effect of an intervention and generate information about the mechanisms…

Amount: Not stated
Type: Grant

Key facts

Key facts for Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)
Amount	Not stated
Issuer	National Institutes of Health
Who can apply	US companies
Sectors	HealthTech
Deadline	Closes 15 Oct 2027

Unlock application details

See all eligibility criteria, required documents and the official application link. Free account, no card.

Update history

Source: grants.gov ↗

Source checked yesterday

40 days agoagentImported from the official source

Opportunities with the same funding type or region
AI Growth Lab		Closes 27 Sep 2026
BJA FY 2026 Adult Treatment Court Program	up to $2.5M	Closes 30 Oct 2026
BJA FY 2026 Capital Case Litigation Initiative: Improving the Quality of Legal Representation in State Capital Cases	up to $450,000	Closes 29 Oct 2026